Advanced disease progression occurred less often with vutrisiran than placebo in both the overall population (8.0% vs 10.7%) and monotherapy subgroup (8.2% vs 11.1%). Transition to NYHA class IV was ...

Plus: Meta has launched the first AI model from its Superintelligence Labs. This is today's edition of The Download, our ...

Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...

The report highlighted in the April 5 Business article “Study: Advanced degrees in some popular fields often don’t pay off” ...

The University of Dayton is developing and adapting curriculum as part of its broader AI strategy to prepare students to use the technology skillfully and thoughtfully in their careers.